Epicrispr gene silencer is 1st drug to boost muscle in form of muscular dystrophy, biotech says Read more
Fierce Biotech Layoff Tracker 2026: Biogen sheds Apellis R&D roles; ADC Tx slims workforce Read more
Biogen ends Apellis research programs, cuts ‘small number’ of roles after $5.6B buyout Read more
